About ArunA Bio
ArunA Bio is a company based in Athens (United States) founded in 2017.. ArunA Bio has raised $38.51 million across 13 funding rounds from investors including HHS, NIH SBIR/STTR and Eshelman Ventures. ArunA Bio offers products and services including AB126 and Neural Exosome Platform. ArunA Bio operates in a competitive market with competitors including BioLife Solutions, Ribometrix, ReNAgade, RoosterBio and Creyon Bio, among others.
- Headquarter Athens, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aruna Bio, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$38.51 M (USD)
in 13 rounds
-
Latest Funding Round
$679.41 K (USD), Grant
Jun 01, 2022
-
Investors
HHS
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ArunA Bio
ArunA Bio offers a comprehensive portfolio of products and services, including AB126 and Neural Exosome Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Exosome that reduces neuro-inflammation and promotes neuro-protection.
Platform enabling access across the blood-brain barrier for treatments.
Unlock access to complete
Unlock access to complete
Funding Insights of ArunA Bio
ArunA Bio has successfully raised a total of $38.51M across 13 strategic funding rounds. The most recent funding activity was a Grant round of $679.41 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Grant — $679,411
-
First Round
First Round
(27 Jun 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Grant - ArunA Bio | Valuation |
investors |
|
| Apr, 2021 | Amount | Series B - ArunA Bio | Valuation |
investors |
|
| Sep, 2019 | Amount | Grant - ArunA Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ArunA Bio
ArunA Bio has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, NIH SBIR/STTR and Eshelman Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ArunA Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ArunA Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aruna Bio Comparisons
Competitors of ArunA Bio
ArunA Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, Ribometrix, ReNAgade, RoosterBio and Creyon Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
RNA-targeted drug discovery platform using three-dimensional structural analysis is provided.
|
|
| domain | founded_year | HQ Location |
RNA-based medicines are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| domain | founded_year | HQ Location |
Oligonucleotide-based drug development platform is provided using AI models.
|
|
| domain | founded_year | HQ Location |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aruna Bio
Frequently Asked Questions about ArunA Bio
When was ArunA Bio founded?
ArunA Bio was founded in 2017.
Where is ArunA Bio located?
ArunA Bio is headquartered in Athens, United States.
Is ArunA Bio a funded company?
ArunA Bio is a funded company, having raised a total of $38.51M across 13 funding rounds to date. The company's 1st funding round was a Grant of $4.5M, raised on Jun 27, 2008.
What does ArunA Bio do?
Founded in 2017 and based in Athens, United States, ArunA Bio operates in the biotechnology sector. A neural exosome platform is utilized to create therapeutics that cross the blood-brain barrier. Anti-inflammatory, self-repair, and protective mechanisms in the body are enhanced to address neurodegenerative disorders. The lead candidate, AB126, targets stroke, Parkinsons disease, and multiple sclerosis.
Who are the top competitors of ArunA Bio?
ArunA Bio's top competitors include FabricNano, RoosterBio and BioLife Solutions.
What products or services does ArunA Bio offer?
ArunA Bio offers AB126 and Neural Exosome Platform.
Who are ArunA Bio's investors?
ArunA Bio has 3 investors. Key investors include HHS, NIH SBIR/STTR, and Eshelman Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.